| News

Oettinger Davidoff AG: Swiss precision paired with caribbean expertise


Oettinger Davidoff AG, with sales of over half a billion Swiss francs and 3,600 employees around the world, is a Swiss family owned company rooted in Basel. The company is dedicated to the business of producing, marketing, distributing and retailing premium-branded cigars, tobacco products and accessories.

Beat Hauenstein, CEO Oettinger Davidoff AG

The premium-branded cigar business is anchored around Davidoff, and includes brands such as AVO, Camacho, Cusano, Griffin’s, Private Stock, Zino and Zino Platinum. Oettinger Davidoff AG is also the sole agent of many brands in several countries such as Haribo in Switzerland. The company’s corporate responsibility focuses on optimizing the value chain, personnel development and respectful treatment of nature, employees and business partners around the world with a long-term perspective.

Rooted in Basel since 1875

In 2017, the company proudly inaugurated its new headquarters – the Maison Davidoff – at the very same location where it has been since 1930. The newly built global headquarters in Basel is underlying the commitment to the city and to its Swiss heritage.

The Maison Davidoff, designed by renowned Diener & Diener Architects, is the physical manifestation of the corporate culture and combines traditional and transparent formal elements with sustainable and innovative design and building technology. It hosts 140 employees in the areas of marketing & innovation, procurement & production, commerce, human resources, finances and corporate communications.

Favoured by its geographical location in the heart of Europe and thus easily accessible from all over the world, Basel also boasts a very dynamic and sustainable economy, which always allowed the company to operate successfully. Located in the tri-border region of Switzerland, Germany and France and with a long history as a trading hub, the Basel Area is a true melting pot for cultures and industries, which also enriches the culture of Oettinger Davidoff.

Tradition – Innovation – Passion

The history and success of the company is based on two great pioneers: Zino Davidoff and Dr. Ernst Schneider. Zino Davidoff (1906 – 1994) ran a cigar shop in Geneva, invented the first walk-in humidor ever and launched the first Davidoff cigar with the iconic white Davidoff ring in the year 1968. The Basel-born Dr. Ernst Schneider (1921 – 2009), took over the management of the family company in 1961, and in 1970 purchased Zino Davidoff’s shop in Geneva, including the valuable name rights.

While Zino Davidoff acted as the company’s brand ambassador, Dr. Schneider headed the company from his offices in Basel, building and executing his strategy to become a globally renowned brand and company.

Another important milestone in the history of the company was the change of the production from Cuba to the Dominican Republic in 1991. Still today, all Davidoff cigars are produced in Santiago de los Caballeros, in the Dominican Republic, and the art of blending a cigar with tobaccos from all corners of the world has continuously innovated over the years.

Tradition, innovation, passion and integrity are the values which drive the 3,600 employees to fulfill the company’s premium promise to its customers, namely to delight and surprise with exciting and innovative products to provide joyful experiences of “time beautifully filled”.

Share this article

Sign up to receive our newsletter in your inbox.

You might also be interested in

Basel Area Business & Innovation, Innovation

docdok.health involved in coronavirus research project

A research project is investigating the improvement in the condition of patients who have been hospitalized due to COVID-19. docdok.health based in Basel is contributing the smartphone app for the project.

Read More
Basel Area Business & Innovation, Innovation

Celonic agrees cooperation to combat coronavirus

The Basel-based biopharmaceutical company Celonic Group has agreed a partnership with Airway Therapeutics from the USA. Together, the two companies are planning to develop a drug to treat coronavirus.

Read More
Basel Area Business & Innovation, Innovation, Invest

Idorsia receives payment of 45 million US dollars

The Allschwil-based pharmaceutical company Idorsia receives a payment of 45 million US dollars as part of an agreement with Neurocrine Biosciences and shall also be entitled to claim milestone payments in future. Neurocrine has exercised a licensing option for a drug developed by Idorsia to treat epilepsy..

Read More
Basel Area Business & Innovation, Innovation

Humard robot disinfects using UV light

Humard has developed a robot that can disinfect spaces using UV light. For this, the system manufacturer from the canton of Jura has adapted a mobile industrial robot that is otherwise used in warehouse logistics.

Read More
Basel Area Business & Innovation, Innovation, Invest

Roche authorized to distribute coronavirus antibody tests

Roche has received Emergency Use Authorization in the USA for an antibody test in connection with the novel coronavirus. The tests are already being distributed around the world. In May, production capacities are to already be scaled up to the high double-digit million area.

Read More
Basel Area Business & Innovation, Invest

Basel is the most popular Swiss location for headquarters

Basel is valued as a location for company headquarters. In a rating from the fDi Intelligence platform of the Financial Times, Basel achieves eighth place in Europe. No other Swiss city does better.

Read More
Basel Area Business & Innovation, Innovation, Invest, Switzerland Innovation Park

Healthtech sector growing rapidly in the Basel Area

The investment and innovation promotion agency Basel Area Business & Innovation, previously known as BaselArea.swiss, can look back on a successful year in 2019. In this regard, positive developments in the healthtech sector and in Switzerland Innovation Park Basel Area stand out.

Read More
Basel Area Business & Innovation, Innovation, Invest

Support program has roots in Basel

The online program Selfapy supports people suffering from mental health conditions during the coronavirus lockdown. BaselArea.swiss has provided startup help by way of its DayOne initiative.

Read More
Basel Area Business & Innovation, Innovation

University Hospital Basel treats coronavirus patients with plasma

The University Hospital Basel is the first Swiss hospital to have treated two Covid-19 patients with the plasma from a patient who has recovered from the virus, which means that they are receiving the appropriate antibodies. This method is a potential therapeutic option.

Read More
Basel Area Business & Innovation, Innovation

Botnar Research Center advancing research into coronavirus

The Basel-based Botnar Research Center for Child Health is providing capital in the amount of 15 million Swiss francs to its four partner institutions. In this way, the University of Basel should be in a position to advance research into dealing with the coronavirus outbreak.

Read More
1 2 3 18

Do you have a question? We'd like to hear from you.